Chia Nan University of Pharmacy & Science Institutional Repository:Item 310902800/34505
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 18295/20522 (89%)
Visitors : 49957482      Online Users : 1274
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/34505


    題名: Cedrus atlantica Extract Suppress Glioblastoma Growth through Promotion of Genotoxicity and Apoptosis: In Vitro and In Vivo Studies
    作者: Chang, Kai-Fu
    Chang, Jinghua Tsai
    Huang, Xiao-Fan
    Huang, Ya-Chih
    Li, Chia-Yu
    Weng, Jun-Cheng
    Hsiao, Chih-Yen
    Hsu, Hui-Ju
    Tsai, Nu-Man
    貢獻者: Chung Shan Med Univ, Inst Med
    Chung Shan Med Univ, Dept Med Lab & Biotechnol
    Nanhua Univ, Dept Life & Death
    Chang Gung Univ, Dept Med Imaging & Radiol Sci
    Ditmanson Med Fdn, Dept Internal Med, Div Nephrol, Chia Yi Christian Hosp
    Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm
    Chung Shan Med Univ Hosp, Clin Lab
    關鍵詞: Glioblastoma
    Cedrus atlantica
    DNA damage
    cell apoptosis
    drug combination
    日期: 2021
    上傳時間: 2023-11-11 11:59:43 (UTC+8)
    出版者: IVYSPRING INT PUBL
    摘要: Glioblastoma (GBM) is the most common malignant primary brain tumor in humans, exhibiting highly infiltrative growth and drug resistance to conventional chemotherapy. Cedrus atlantica (CAt) extract has been shown to decrease postoperative pain and inhibit the growth of K562 leukemia cells. The aim of this study was to assess the anti-GBM activity and molecular mechanism of CAt extract in vitro and in vivo. The results showed that CAt extract greatly suppressed GBM cells both in vitro and in vivo and enhanced the survival rate in subcutaneous and orthotopic animal models. Moreover, CAt extract increased the level of ROS and induced DNA damage, resulting in cell cycle arrest at the G(0)/G(1) phase and cell apoptosis. Western blotting results indicated that CAt extract regulates p53/p21 and CDK4/cyclin D1 protein expression and activates extrinsic and intrinsic apoptosis. Furthermore, CAt extract enhanced the cytotoxicity of Temozolomide and decreased AKT/mTOR signaling by combination treatment. In toxicity assays, CAt extract exhibited low cytotoxicity toward normal cells or organs in vitro and in vivo. CAt extract suppresses the growth of GBM by induction of genotoxicity and activation of apoptosis. The results of this study suggest that CAt extract can be developed as a therapeutic agent or adjuvant for GBM treatment in the future.
    關聯: INT J MED SCI, v.18, n.11, pp.2417-2430
    顯示於類別:[Dept. of Hospital and Health (including master's program)] Periodical Articles

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    ijms.54468.pdf2440KbAdobe PDF270檢視/開啟
    index.html0KbHTML700檢視/開啟


    在CNU IR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback